Holen Sie sich die Stockscreener-App
11.54
8.12%
-1.02
Schlusskurs vom Vortag:
$12.56
Offen:
$12.52
24-Stunden-Volumen:
63,575
Relative Volume:
0.63
Marktkapitalisierung:
$990.39M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
123.42
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
-3.67%
1M Leistung:
+5.29%
6M Leistung:
-3.51%
1J Leistung:
-18.33%
1-Tages-Spanne:
$11.54
$12.73
1-Wochen-Bereich:
$11.54
$12.80
52-Wochen-Spanne:
$8.26
$26.37
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(619) 949-3681
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
11.54 | 990.39M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
Gyre Therapeutics president Ma Songjiang sells $49,380 in stock - Investing.com
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects - TipRanks
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $46,360 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Gyre Therapeutics president sells $45,380 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 - MSN
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - Armenian Reporter
Gyre therapeutics president Ma Songjiang sells $48,029 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $48,029 in stock By Investing.com - Investing.com Canada
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in January - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $22,360.00 in Stock - MarketBeat
Gyre Therapeutics president sells $45,380 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 - MSN
Barclays PLC Has $116,000 Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 - MSN
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
Feb 19 '25 |
Sale |
12.29 |
2,000 |
24,580 |
2,865,260 |
| Ma Songjiang | President |
Feb 18 '25 |
Sale |
12.49 |
2,000 |
24,980 |
2,867,260 |
| Ma Songjiang | President |
Feb 14 '25 |
Sale |
11.94 |
2,000 |
23,880 |
2,869,260 |
| Ma Songjiang | President |
Feb 13 '25 |
Sale |
11.69 |
2,000 |
23,380 |
2,871,260 |
| Ma Songjiang | President |
Feb 12 '25 |
Sale |
11.49 |
2,000 |
22,980 |
2,873,260 |
| Ma Songjiang | President |
Feb 10 '25 |
Sale |
11.90 |
2,000 |
23,800 |
2,877,138 |
| Ma Songjiang | President |
Feb 11 '25 |
Sale |
11.52 |
1,878 |
21,635 |
2,875,260 |
| Ma Songjiang | President |
Feb 06 '25 |
Sale |
12.85 |
2,000 |
25,700 |
2,881,138 |
| Ma Songjiang | President |
Feb 07 '25 |
Sale |
12.16 |
2,000 |
24,320 |
2,879,158 |
| Ma Songjiang | President |
Feb 05 '25 |
Sale |
12.39 |
2,000 |
24,789 |
2,883,138 |
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):